Alternatives to Kanso Diagnostics

MeMed develops and commercializes host immune response diagnostic solutions to address complex clinical dilemmas and improve patient outcomes.

Leveraging the adaptive immune system to diagnose and treat disease.

HaystackAnalytics is a startup focused on providing AI-powered analytics for software development teams.

Visby Medical develops and manufactures instrument-free, PCR-quality rapid diagnostic tests for infectious diseases at the point of care.

Sight Diagnostics develops rapid, accurate, and convenient diagnostic testing solutions, including a complete blood count analyzer.

Firefly Neuroscience provides objective brain function assessments for mental illness using FDA-cleared Brain Network Analytics (BNA™) technology.

Nucleix is a liquid biopsy company developing early cancer detection solutions using methylation analysis.

Develops in-vitro diagnostic platforms for rapid antimicrobial susceptibility testing.

Scopio Labs transforms cell morphology analysis with fully digital platforms and diagnostic support for faster, more accurate disease detection.

Pentaomix develops a breakthrough biopsy imaging modality for unprecedented accuracy in pathology analysis.

Cue is a health technology company developing and manufacturing a molecular diagnostic platform for rapid, lab-quality health testing at home.

Developing a liquid biopsy blood test for early disease detection and monitoring using epigenetic information.

Clair Labs develops medical-grade, contact-free vital signs sensing technology powered by deep learning and computer vision for proactive healthcare.

AI-powered diagnostic platform detecting and interpreting inaccessible body infra-sounds for enhanced medical diagnosis.

EarliPoint Health develops a digital health platform for earlier identification and treatment of autism spectrum disorder (ASD) in children.

Developing novel diagnostics to predict patient response to immunotherapy.

Develops toilet-integrated diagnostic technology for early health condition detection.

Developing autonomous robotic phlebotomy devices to standardize blood collection and improve patient care.

Developing advanced diagnostic technology to expand global access to healthcare.

Non-invasive device for real-time measurement of LVEDP and other vital hemodynamic indices.